Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus
Conclusions: The use of quercetin against the background of basic therapy in patients with COVID-19 and concomitant T2DM reliably reduces the level of acute-phase indices, has an important clinical significance for reducing endothelial dysfunction and for preventing thrombotic complications.
Authors
- Andriy Liubomyrovych Protsyk (ORCID: https://orcid.org/0000-0003-2041-5337)
- Oleksandr P. Boichuk (ORCID: https://orcid.org/0000-0003-0646-6533)
- Taras Kobryn (ORCID: https://orcid.org/0000-0003-4381-6045)
- Sergiy Fedorov (ORCID: https://orcid.org/0000-0002-2202-4279)
- Руслан Мізюк (ORCID: https://orcid.org/0000-0002-7829-9044)
- Oleksandra Pryshliak (ORCID: https://orcid.org/0000-0002-3256-5108)
- Zoriana Tylishchak (ORCID: https://orcid.org/0000-0002-7891-2849)
Institutions
- Ivano-Frankivsk National Medical University (UA)
Publication Details
- Journal
- Wiadomości Lekarskie
- Published
- 2024-12-06
- DOI
- https://doi.org/10.36740/wlek/191875
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78